ATE102836T1 - Arzneimittel fuer die behandlung oder die verhuetung von infektionen mit hiv durch immunisierung, und verfahren zur herstellung. - Google Patents

Arzneimittel fuer die behandlung oder die verhuetung von infektionen mit hiv durch immunisierung, und verfahren zur herstellung.

Info

Publication number
ATE102836T1
ATE102836T1 AT89403495T AT89403495T ATE102836T1 AT E102836 T1 ATE102836 T1 AT E102836T1 AT 89403495 T AT89403495 T AT 89403495T AT 89403495 T AT89403495 T AT 89403495T AT E102836 T1 ATE102836 T1 AT E102836T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
immunization
medications
manufacture
Prior art date
Application number
AT89403495T
Other languages
English (en)
Inventor
Michel Grandgeorge
Francois Pelloquin
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of ATE102836T1 publication Critical patent/ATE102836T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT89403495T 1988-12-15 1989-12-15 Arzneimittel fuer die behandlung oder die verhuetung von infektionen mit hiv durch immunisierung, und verfahren zur herstellung. ATE102836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8816580A FR2640511B1 (fr) 1988-12-15 1988-12-15 Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
EP89403495A EP0374053B1 (de) 1988-12-15 1989-12-15 Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
ATE102836T1 true ATE102836T1 (de) 1994-04-15

Family

ID=9373004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89403495T ATE102836T1 (de) 1988-12-15 1989-12-15 Arzneimittel fuer die behandlung oder die verhuetung von infektionen mit hiv durch immunisierung, und verfahren zur herstellung.

Country Status (13)

Country Link
EP (1) EP0374053B1 (de)
JP (1) JPH03505738A (de)
CN (1) CN1045035A (de)
AT (1) ATE102836T1 (de)
AU (1) AU627540B2 (de)
CA (1) CA2005365C (de)
DE (1) DE68913932T2 (de)
DK (1) DK192990A (de)
ES (1) ES2062079T3 (de)
FR (1) FR2640511B1 (de)
IE (1) IE63831B1 (de)
WO (1) WO1990006773A1 (de)
ZA (1) ZA899533B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE244888T1 (de) * 1993-02-05 2003-07-15 Epigen Inc Humanes carcinoma-antigen (hca), hca antikörper, hca immunoassays, aufzeichnungsmethoden und therapy
CN106110422B (zh) * 2016-07-01 2019-02-01 翁炳焕 艾滋病免疫治疗吸附器

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604947A1 (de) * 1986-02-17 1987-08-20 Biotest Pharma Gmbh Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
AU618555B2 (en) * 1987-08-11 1992-01-02 Biomune Corporation Hyper-immune globulin against hiv

Also Published As

Publication number Publication date
CN1045035A (zh) 1990-09-05
DE68913932T2 (de) 1994-07-07
FR2640511A1 (fr) 1990-06-22
ES2062079T3 (es) 1994-12-16
WO1990006773A1 (fr) 1990-06-28
FR2640511B1 (fr) 1993-04-23
ZA899533B (en) 1990-12-28
DK192990D0 (da) 1990-08-14
CA2005365C (en) 1995-12-12
CA2005365A1 (en) 1990-06-15
JPH03505738A (ja) 1991-12-12
IE894005L (en) 1990-06-15
EP0374053A1 (de) 1990-06-20
IE63831B1 (en) 1995-06-14
AU627540B2 (en) 1992-08-27
AU4806290A (en) 1990-07-10
DE68913932D1 (de) 1994-04-21
EP0374053B1 (de) 1994-03-16
DK192990A (da) 1990-08-14

Similar Documents

Publication Publication Date Title
EP0726758A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
EP1375511A3 (de) Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
NO943653D0 (no) Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
DE69005908D1 (de) Monoklonale Antikörper zur Behandlung nach einem Kontakt mit Tollwutvirus.
SE9000333D0 (sv) Monoklonal antikropp
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
ATE102836T1 (de) Arzneimittel fuer die behandlung oder die verhuetung von infektionen mit hiv durch immunisierung, und verfahren zur herstellung.
ATE408418T1 (de) Methoden zur inhibition von hiv-assoziierten krankheiten mittels monoklonaler antikörper gegen sich selbstgerichtete zytotoxische t-zellen
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
DE3854857D1 (de) Verhütung und behandlung einer retrovirenkrankheit
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
CA2160696A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
CA2079230A1 (en) Bcrf1 antagonists for treating epstein-barr virus infections
CA2156416A1 (en) Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee